Advertisement

Hormone Replacement Therapy and Lipids

  • H. Honjo
  • M. Urabe
  • K. Tanaka
  • T. Kashiwagi
  • T. Okubo
  • H. Tsuchiya
  • K. Iwasa
  • N. Kikuchi
  • T. Yamamoto
Conference paper
Part of the Ernst Schering Research Foundation Workshop book series (SCHERING FOUND, volume 4)

Abstract

In 1997, the average life span for Japanese women was 83.82 years, the highest worldwide average for 13 years. However, sometimes the faces of Japanese women don’t look so well. Their quality of life is also very important. The second most common cause of death in women is cerebrovascular disease, and the third is heart disease. Both of these conditions are closely associated with arterial sclerosis (Table 1).

Keywords

Postmenopausal Woman Endometrial Cancer Arterial Sclerosis Estrogen Replacement Therapy Human Vascular Smooth Muscle Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117: 1016–1037PubMedCrossRefGoogle Scholar
  2. Hirota K, Honjo H, Shintani M (1995) Factors on menopause — a study in en-docrine research group (1994). Adv Obstet Gynecol 47: 389–392Google Scholar
  3. Honjo H (1991) Clinical results of mevalotin: study of usefulness against hy-percholesterolemia in the climacteric woman. J Am Med Assoc (Japanese version) 12 (appendix): 26–29Google Scholar
  4. Honjo H (1995) Climacteric and elderly out-patients’ manual — invitation to queen’s corner, 1st edn, 2nd issue. Kinpodo, KyotoGoogle Scholar
  5. Honjo H (1998) More information about HRT, Chizin-sha, KyotoGoogle Scholar
  6. Honjo H, Tanaka K, Urabe M, Naitoh K, Ogino Y, Yamamoto T, Okada H (1992) Menopause and hyperlipidemia: pravastatin lowers lipid levels without decreasing endogenous estrogens. Clin Ther 14: 699–707PubMedGoogle Scholar
  7. Honjo H, Tanaka K, Kashiwagi T, Okada H, Takanashi K, Yoshizawa I (1994) Women of menopausal age and hyperlipidemia: effects of estrogens and an HMG-CoA reductase inhibitor. In: Yamamoto A (ed) Multiple risk factors in cardiovascular disease. Churchill Livingstone, Tokyo, pp 81–84Google Scholar
  8. Honjo H, Tanaka K, Kashiwagi T, Urabe M, Okada H, Hayashi M, Hayashi K (1995) Senile dementia Alzheimer’s type and estrogen. Horm Metab Res 27: 204–207PubMedCrossRefGoogle Scholar
  9. Honjo H, Urabe M, Iwasa K,Okubo I, Tsuchiya H, Kikuchi N, Yamamoto T, Fushiki S, Mizuno T, Nakajima K, Hayashi M, Hayashi K (1997) Estrogen treatment for senile dementia — Alzheimer’s type. In: Wren BG (ed) Progress in the management of the menopause. Parthenon, New York, pp 302–307Google Scholar
  10. Honjo H, Iwasa K, Urabe M (1998) Clinical studies of estrogen therapy for dementia, J Brit Menopause Soc 4: 12–17Google Scholar
  11. Japanese Ministry of Health and Welfare, 31 August 1996; Population Development Statistics for 1995, 404–405Google Scholar
  12. Japanese Ministry of Health and Welfare, 28 August 1998; Simple life table in 1997Google Scholar
  13. Koseisho (Ministry of Health and Welfare) (Jan 1993). Outline of the 4th Cardiac Disease Basic Survey (Nov 1990) by the Disease Control Division, Health Service Bureau, Mainichi (newspaper), 4 Feb 1993Google Scholar
  14. Mahley RW (1988) Apolipoprotein E; cholesterol transport protein with expanding role in cell biology. Science 240: 622–629PubMedCrossRefGoogle Scholar
  15. Ohkura T, Teshima Y, Isse K, Matsuda H, Inoue T, Sakai Y, Iwasaki N, Yaoi Y (1995) Estrogen increases cerebral and cerebellar blood flows in postmenopausal women. Menopause 2: 13–8CrossRefGoogle Scholar
  16. Paganini-Hill A, Henderson VW (1996) Estrogen replacement therapy and risk of Alzheimer’s disease. Arch Intern Med 156: 2213–2217PubMedCrossRefGoogle Scholar
  17. Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P (1993) Beneficial effect of estrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 342: 133–6PubMedCrossRefGoogle Scholar
  18. Tang M-X, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer’s disease. Lancet 348: 429–432PubMedCrossRefGoogle Scholar
  19. Udoff L, Langenberg P, Adashi EY (1995) Combined continuous hormone replacement therapy: a critical review. Obstet Gynecol 86: 306–16PubMedCrossRefGoogle Scholar
  20. Urabe M, Yamamoto T, Kashiwagi T, Okubo T, Tsuchiya H, Iwasa K, Kikuchi N, Yokota K, Hosokawa K, Honjo H (1996) Effect of estrogen replacement therapy on hepatic triglyceride lipase, lipoprotein lipase and lipids including apolipoprotein E in climacteric and elderly women. Endocr J 43: 737–742Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • H. Honjo
  • M. Urabe
  • K. Tanaka
  • T. Kashiwagi
  • T. Okubo
  • H. Tsuchiya
  • K. Iwasa
  • N. Kikuchi
  • T. Yamamoto

There are no affiliations available

Personalised recommendations